Compounding Risk Alerts

Compounding Risk Alert

The information provided on this webpage is intended to alert health care professionals of adverse event reports related to compounded drugs. Providing this information to health care professionals should further FDA’s goal of protecting patients from unsafe, ineffective, and poor quality compounded drugs.

Please contact compounding@fda.hhs.gov if you have any questions regarding the information provided in a compounding risk alert below:

FDA encourages health care professionals to report adverse events and product quality defects associated with compounded drugs to FDA’s MedWatch Adverse Event Reporting program: 


Page Last Updated: 08/04/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English